搜索临床试验以:芬戈莫德试验制剂
总计10813个结果
-
M.D. Anderson Cancer CenterSpectrum Pharmaceuticals, Inc撤销
-
Kirby InstituteNational Heart, Lung, and Blood Institute (NHLBI); St Vincent's Hospital, Sydney完全的
-
OHSU Knight Cancer InstituteOregon Health and Science University尚未招聘II 期胰腺癌 AJCC v8 | III 期胰腺癌 AJCC v8 | IV 期胰腺癌 AJCC v8 | 转移性胰腺导管腺癌 | 局部晚期胰腺导管腺癌 | 不可切除的胰腺癌美国
-
National Cancer Institute (NCI)完全的
-
Mayo ClinicNational Cancer Institute (NCI)招聘中
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI); National Marrow... 和其他合作者终止
-
M.D. Anderson Cancer Center完全的
-
OHSU Knight Cancer InstituteOregon Health and Science University完全的
-
Taizhou HospitalFirst Affiliated Hospital of Zhejiang University; Taizhou First People's Hospital; Academy Military... 和其他合作者未知
-
European Organisation for Research and Treatment...Novartis尚未招聘
-
Mayo ClinicNational Cancer Institute (NCI)招聘中
-
Nicola Goekbuget完全的
-
Federal Research Institute of Pediatric Hematology...招聘中儿童急性淋巴细胞白血病亚美尼亚, 白俄罗斯, 吉尔吉斯斯坦, 俄罗斯联邦, 乌兹别克斯坦
-
Darnitsa Pharmaceutical CompanyInternational Pharmaceutical Research Center完全的
-
GlaxoSmithKline完全的
-
The Korean Academy of Tuberculosis and Respiratory...GlaxoSmithKline完全的
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
Dwight Owen招聘中转移性肺非小细胞癌 | IVA 期肺癌 AJCC v8 | IVB 期肺癌 AJCC v8 | IV 期肺癌 AJCC v8 | 复发性肺非小细胞癌美国
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的
-
Emory UniversityNational Cancer Institute (NCI)尚未招聘II 期胰腺癌 AJCC v8 | III 期胰腺癌 AJCC v8 | I 期胰腺癌 AJCC v8 | 可切除的胰腺癌 | 交界性可切除胰腺导管腺癌美国
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)招聘中
-
National Cancer Institute (NCI)主动,不招人
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)主动,不招人转移性胰腺癌 | IV 期胰腺癌 AJCC v6 和 v7 | IV 期结直肠癌 AJCC v7 | IVA 期结直肠癌 AJCC v7 | IVB 期结直肠癌 AJCC v7 | 转移性胃食管结合部腺癌 | 转移性结直肠癌 | 转移性恶性消化系统肿瘤 | 转移性胆道癌美国
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Varian Medical Systems暂停
-
Mayo ClinicNational Cancer Institute (NCI)主动,不招人恶性实体肿瘤 | 卵巢子宫内膜样腺癌 | 卵巢未分化癌 | 宫颈腺癌 | 宫颈腺鳞癌 | 恶性腹膜肿瘤 | 子宫内膜透明细胞腺癌 | 子宫内膜 子宫内膜样腺癌 | 子宫内膜混合细胞腺癌 | 子宫内膜浆液性腺癌 | 子宫内膜未分化癌 | 宫颈鳞状细胞癌 | 不可切除的黑色素瘤 | 卵巢透明细胞腺癌 | 卵巢粘液腺癌 | 恶性女性生殖系统肿瘤 | 输卵管腺癌 | 输卵管移行细胞癌 | 卵巢移行细胞癌 | 临床 IV 期皮肤黑色素瘤 AJCC v8 | 输卵管透明细胞腺癌 | 输卵管子宫内膜样腺癌 | 输卵管粘液腺癌 | 输卵管浆液性腺癌 | 输卵管未分化癌 | 卵巢浆液性腺癌 | 原发性腹膜浆液性腺癌 | 铂类耐药输卵管癌 | 铂类耐药原发性腹膜癌 | 宫颈腺肉瘤 | 宫颈癌肉瘤 | 子宫内膜腺鳞癌 | 子宫内膜粘液腺癌 | 输卵管癌肉瘤 | 输卵管鳞状细胞癌 | 恶性卵巢透明细胞瘤 | 恶... 及其他条件美国
-
Fondazione Italiana Linfomi ONLUSCentro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte未知
-
ANRS, Emerging Infectious Diseases完全的